273 related articles for article (PubMed ID: 27190400)
1. Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.
Flanagan CA; Koller KR; Wolfe AW; Thomas TK; Benowitz NL; Renner CC; Hughes C; Hatsukami DK; Bronars C; Murphy NJ; Day G; Decker PA; Patten CA
Nicotine Tob Res; 2016 Nov; 18(11):2162-2168. PubMed ID: 27190400
[TBL] [Abstract][Full Text] [Related]
2. Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.
Benowitz NL; Flanagan CA; Thomas TK; Koller KR; Wolfe AW; Renner CC; Hughes C; Decker PA; Hatsukami DK; Murphy NJ; Patten C
Int J Circumpolar Health; 2018 Dec; 77(1):1528125. PubMed ID: 30325719
[TBL] [Abstract][Full Text] [Related]
3. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
[TBL] [Abstract][Full Text] [Related]
4. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
Hecht SS; Carmella SG; Murphy SE; Riley WT; Le C; Luo X; Mooney M; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1567-72. PubMed ID: 17684130
[TBL] [Abstract][Full Text] [Related]
5. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
[TBL] [Abstract][Full Text] [Related]
6. [Determination of 4-(methylnirosamino) -4-(3-pyridyl)-1-butanol (NNA) in urine of pregnant women by means of LC/MS/MS].
Florek E; Piekoszewski W; Lechowicz W; Szymańska A; Kornacka MK
Przegl Lek; 2006; 63(10):926-31. PubMed ID: 17288186
[TBL] [Abstract][Full Text] [Related]
7. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
Czoli CD; Hammond D
Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
[TBL] [Abstract][Full Text] [Related]
8. Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations.
Vardavas CI; Fthenou E; Patelarou E; Bagkeris E; Murphy S; Hecht SS; Connolly GN; Chatzi L; Kogevinas M
Tob Control; 2013 May; 22(3):194-200. PubMed ID: 22253001
[TBL] [Abstract][Full Text] [Related]
9. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Murphy SE; Link CA; Jensen J; Le C; Puumala SS; Hecht SS; Carmella SG; Losey L; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1617-23. PubMed ID: 15466978
[TBL] [Abstract][Full Text] [Related]
10. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
11. The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.
Vogel RI; Carmella SG; Stepanov I; Hatsukami DK; Hecht SS
Biomarkers; 2011 Sep; 16(6):491-7. PubMed ID: 21812592
[TBL] [Abstract][Full Text] [Related]
12. Comparison of urine cotinine and the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and their ratio to discriminate active from passive smoking.
Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P; Benowitz NL
Nicotine Tob Res; 2011 Mar; 13(3):202-8. PubMed ID: 21330276
[TBL] [Abstract][Full Text] [Related]
13. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
14. Metabolites of a tobacco-specific carcinogen in urine from newborns.
Lackmann GM; Salzberger U; Töllner U; Chen M; Carmella SG; Hecht SS
J Natl Cancer Inst; 1999 Mar; 91(5):459-65. PubMed ID: 10070946
[TBL] [Abstract][Full Text] [Related]
15. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
[TBL] [Abstract][Full Text] [Related]
16. A tobacco-specific carcinogen in the fetus.
Milunsky A; Carmella SG; Ye M; Hecht SS
Prenat Diagn; 2000 Apr; 20(4):307-10. PubMed ID: 10740203
[TBL] [Abstract][Full Text] [Related]
17. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.
Hecht SS; Carmella SG; Edmonds A; Murphy SE; Stepanov I; Luo X; Hatsukami DK
Tob Control; 2008 Apr; 17(2):128-31. PubMed ID: 18375734
[TBL] [Abstract][Full Text] [Related]
18. Application of an assay for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine for the assessment of tobacco-related harm.
Lu W; Ferguson SG; Nichols DS; Patel R; Jacobson GA
J Pharm Biomed Anal; 2016 Nov; 131():327-332. PubMed ID: 27632782
[TBL] [Abstract][Full Text] [Related]
19. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
Joseph AM; Hecht SS; Murphy SE; Carmella SG; Le CT; Zhang Y; Han S; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2963-8. PubMed ID: 16365017
[TBL] [Abstract][Full Text] [Related]
20. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
